BlackRock Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.54M Buy
459,695
+47,857
+12% +$524K 0.01% 1649
2016
Q3
$4.97M Buy
411,838
+5,784
+1% +$59.1K 0.01% 1485
2016
Q2
$3.5M Buy
406,054
+35,975
+10% +$355K ﹤0.01% 1690
2016
Q1
$3.5M Buy
370,079
+14,572
+4% +$137K ﹤0.01% 1614
2015
Q4
$6.16M Buy
355,507
+1,774
+0.5% +$28.3K 0.01% 1254
2015
Q3
$4.75M Sell
353,733
-5,828
-2% -$117K 0.01% 1421
2015
Q2
$8.12M Buy
359,561
+73,636
+26% +$1.29M 0.01% 1143
2015
Q1
$4.08M Buy
285,925
+3,194
+1% +$46.1K 0.01% 1521
2014
Q4
$2.73M Sell
282,731
-975
-0.3% -$8.66K ﹤0.01% 1802
2014
Q3
$2.58M Buy
283,706
+1,640
+0.6% +$15.6K ﹤0.01% 1808
2014
Q2
$2.79M Buy
282,066
+15,808
+6% +$134K ﹤0.01% 1817
2014
Q1
$3.38M Buy
266,258
+22,209
+9% +$330K ﹤0.01% 1673
2013
Q4
$3.66M Sell
244,049
-5,369
-2% -$69.1K 0.01% 1570
2013
Q3
$2.75M Buy
249,418
+12,259
+5% +$102K ﹤0.01% 1711
2013
Q2
$1.89M Buy
+237,159
New +$1.51M ﹤0.01% 1898

Other funds holding HALO

BlackRock Investment Management's HALO Position: Q4 2016 in Review

BlackRock Investment Management increased its Halozyme (HALO) stake by 12% in Q4 2016, buying an estimated $524K and bringing the position to 459,695 shares worth $4.54M. The position accounts for 0.01% of the portfolio, ranked #1649.

BlackRock Investment Management first reported a position in HALO in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.12M in Q2 2015. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

  • BlackRock Investment Management held 459,695 shares of Halozyme worth $4.54M as of Q4 2016.
  • BlackRock Investment Management bought 47,857 Halozyme shares in Q4 2016, an estimated $524K.
  • Halozyme made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1649 holding.
  • BlackRock Investment Management first reported a position in Halozyme in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Halozyme position peaked at $8.12M in Q2 2015.
  • 168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.